<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01555411</url>
  </required_header>
  <id_info>
    <org_study_id>2011/1475 C</org_study_id>
    <secondary_id>AFIA (initial study name)</secondary_id>
    <nct_id>NCT01555411</nct_id>
  </id_info>
  <brief_title>Akershus Cardiac Examination (ACE) 1950 Study</brief_title>
  <acronym>ACE1950</acronym>
  <official_title>Akershus Cardiac Examination 1950 Study - a Cohort Study on Cardio- and Cerebrovascular Disease in 62-65-year-old Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vestre Viken Hospital Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Akershus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vestre Viken Hospital Trust</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Akershus Cardiac Examination (ACE) 1950 Study is a large, observational, prospective,
      longitudinal, population-based cohort study. The overall aim is to establish an extensive
      cardio- and cerebrovascular age cohort of elderly subjects for various longitudinal long-term
      follow-up studies of cardiovascular and cerebrovascular disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Design: The Akershus Cardiac Examination (ACE) 1950 Study is a population-based, prospective,
      cerebro- and cardiovascular age-cohort study of all men and women born in 1950 in Akershus
      County, Norway.

      Time schedule: Study inclusion and baseline examinations took place in the period September
      2012 - May 2015. Follow-up and sub-studies are ongoing.

      Current status: As per May 2018, follow-up and sub-studies are ongoing.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 2012</start_date>
  <completion_date type="Anticipated">January 2050</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Outcomes related to CVD and CV-associated conditions</measure>
    <time_frame>Maximum 35 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Specific CV endpoints; e.g. acute myocardial infarction, heart failure, atrial fibrillation, etc.</measure>
    <time_frame>Maximum 35 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specific CV-associated conditions, including renal, cerebrovascular, pulmonary, etc.</measure>
    <time_frame>Maximum 35 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specific clinical phenotypes; e.g. myocardial and arterial structure and function, lung function, etc.</measure>
    <time_frame>Maximum 35 years</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Impact of left atrial size and function measurements by echocardiography on stroke risk in an 62-65-year-old cohort</measure>
    <time_frame>Within 35 years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Relation between cognitive function and sub-clinical CVD in a 62-65-year-old Norwegian population cohort</measure>
    <time_frame>Maximum 35 years</time_frame>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">3706</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Heart Failure</condition>
  <condition>Mild Cognitive Impairment</condition>
  <condition>Cardiovascular Diseases</condition>
  <condition>Cerebrovascular Disorders</condition>
  <arm_group>
    <arm_group_label>No treatment</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples, including for genetic testing, and urine.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Residents of Akershus County, Norway, born in 1950.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Resident in Akershus County (as per October 2011, prior to study invitation)

          -  Born in the year of 1950

          -  Ability to consent to participation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>62 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arnljot Tveit, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Vestre Viken Hospital Trust, Department of Medical Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Helge Røsjø, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Akershus</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Trygve Berge - member of steering committee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vestre Viken Hospital Trust, Department of Medical Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pål Smith - member of steering committee, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Akershus</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kjetil Steine - member of steering committee, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Akershus</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Torbjørn Omland - member of steering committee, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Akershus</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Magnus N Lyngbakken - member of steering committee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Akershus</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Akershus University Hospital</name>
      <address>
        <city>Lørenskog</city>
        <state>Akershus</state>
        <zip>1478</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vestre Viken HT, Baerum Hospital, Department of Medical Research</name>
      <address>
        <city>Sandvika</city>
        <state>Akershus</state>
        <zip>3004</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <link>
    <url>http://www.ace1950.no</url>
    <description>Study website</description>
  </link>
  <reference>
    <citation>Berge T, Vigen T, Pervez MO, Ihle-Hansen H, Lyngbakken MN, Omland T, Smith P, Steine K, Røsjø H, Tveit A; ACE 1950 Study Group. Heart and Brain Interactions--the Akershus Cardiac Examination (ACE) 1950 Study Design. Scand Cardiovasc J. 2015;49(6):308-15. doi: 10.3109/14017431.2015.1086813. Epub 2015 Sep 12.</citation>
    <PMID>26364744</PMID>
  </reference>
  <results_reference>
    <citation>Ihle-Hansen H, Vigen T, Berge T, Einvik G, Aarsland D, Rønning OM, Thommessen B, Røsjø H, Tveit A, Ihle-Hansen H. Montreal Cognitive Assessment in a 63- to 65-year-old Norwegian Cohort from the General Population: Data from the Akershus Cardiac Examination 1950 Study. Dement Geriatr Cogn Dis Extra. 2017 Sep 28;7(3):318-327. doi: 10.1159/000480496. eCollection 2017 Sep-Dec.</citation>
    <PMID>29118784</PMID>
  </results_reference>
  <results_reference>
    <citation>Berge T, Brynildsen J, Larssen HKN, Onarheim S, Jenssen GR, Ihle-Hansen H, Christophersen IE, Myrstad M, Røsjø H, Smith P, Tveit A. Systematic screening for atrial fibrillation in a 65-year-old population with risk factors for stroke: data from the Akershus Cardiac Examination 1950 study. Europace. 2018 Nov 1;20(FI_3):f299-f305. doi: 10.1093/europace/eux293.</citation>
    <PMID>29095966</PMID>
  </results_reference>
  <results_reference>
    <citation>Berge T, Lyngbakken MN, Ihle-Hansen H, Brynildsen J, Pervez MO, Aagaard EN, Vigen T, Kvisvik B, Christophersen IE, Steine K, Omland T, Smith P, Røsjø H, Tveit A. Prevalence of atrial fibrillation and cardiovascular risk factors in a 63-65 years old general population cohort: the Akershus Cardiac Examination (ACE) 1950 Study. BMJ Open. 2018 Aug 1;8(7):e021704. doi: 10.1136/bmjopen-2018-021704.</citation>
    <PMID>30068617</PMID>
  </results_reference>
  <results_reference>
    <citation>Ihle-Hansen H, Vigen T, Ihle-Hansen H, Rønning OM, Berge T, Thommessen B, Lyngbakken MN, Orstad EB, Enger S, Nygård S, Røsjø H, Tveit A. Prevalence of Carotid Plaque in a 63- to 65-Year-Old Norwegian Cohort From the General Population: The ACE (Akershus Cardiac Examination) 1950 Study. J Am Heart Assoc. 2018 May 8;7(10). pii: e008562. doi: 10.1161/JAHA.118.008562.</citation>
    <PMID>29739796</PMID>
  </results_reference>
  <results_reference>
    <citation>Chandra A, Røsjø H, Eide IA, Vigen T, Ihle-Hansen H, Orstad EB, Rønning OM, Lyngbakken MN, Berge T, Schmidt EB, Omland T, Tveit A, Svensson M. Plasma marine n-3 polyunsaturated fatty acids and cardiovascular risk factors: data from the ACE 1950 study. Eur J Nutr. 2020 Jun;59(4):1505-1515. doi: 10.1007/s00394-019-02007-3. Epub 2019 May 23.</citation>
    <PMID>31123865</PMID>
  </results_reference>
  <results_reference>
    <citation>Vigen T, Ihle-Hansen H, Lyngbakken MN, Berge T, Thommessen B, Ihle-Hansen H, Orstad EB, Enger S, Ariansen I, Røsjø H, Tveit A, Rønning OM. Blood pressure at age 40 predicts carotid atherosclerosis two decades later: data from the Akershus Cardiac Examination 1950 Study. J Hypertens. 2019 Oct;37(10):1982-1990. doi: 10.1097/HJH.0000000000002131.</citation>
    <PMID>31116158</PMID>
  </results_reference>
  <results_reference>
    <citation>Ihle-Hansen H, Vigen T, Berge T, Hagberg G, Engedal K, Rønning OM, Thommessen B, Lyngbakken MN, Nygård S, Røsjø H, Tveit A, Ihle-Hansen H. Carotid Atherosclerosis and Cognitive Function in a General Population Aged 63-65 Years: Data from the Akershus Cardiac Examination (ACE) 1950 Study. J Alzheimers Dis. 2019;70(4):1041-1049. doi: 10.3233/JAD-190327.</citation>
    <PMID>31306128</PMID>
  </results_reference>
  <results_reference>
    <citation>Aagaard EN, Kvisvik B, Pervez MO, Lyngbakken MN, Berge T, Enger S, Orstad EB, Smith P, Omland T, Tveit A, Røsjø H, Steine K. Left ventricular mechanical dispersion in a general population: Data from the Akershus Cardiac Examination 1950 study. Eur Heart J Cardiovasc Imaging. 2020 Feb 1;21(2):183-190. doi: 10.1093/ehjci/jez210.</citation>
    <PMID>31504360</PMID>
  </results_reference>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>March 13, 2012</study_first_submitted>
  <study_first_submitted_qc>March 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 15, 2012</study_first_posted>
  <last_update_submitted>October 21, 2019</last_update_submitted>
  <last_update_submitted_qc>October 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiovascular epidemiology</keyword>
  <keyword>Prospective, observational cohort study</keyword>
  <keyword>Biomarkers</keyword>
  <keyword>Cardio- and cerebrovascular imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cerebrovascular Disorders</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

